Bruker Corp. Stock
Price
Target price
€53.53
€53.53
-1.290%
-0.69
-1.290%
€51.79
26.06.26 / Tradegate
WKN: 813534 / Symbol: BRKR / Name: Bruker / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bruker Corp. Stock
We can see a decrease in the price for Bruker Corp.. Compared to yesterday it has lost -€0.690 (-1.290%).
With 14 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
However, we have a potential of -4.73% for Bruker Corp. as the target price of 51 € is below the current price of 53.53 €.
For the coming years our community has positive and negative things to say abot the Bruker Corp. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -1.290% | 7.555% | 32.648% | 48.529% | 31.233% | -20.696% | - |
| Healthequity Inc. | -0.680% | -0.685% | -2.685% | -18.079% | -7.051% | 31.818% | 4.047% |
| Omnicell Inc. | -0.580% | 1.796% | -10.526% | 40.496% | -12.371% | -46.457% | -72.358% |
| Myriad Genetics | -0.720% | 20.751% | 43.083% | 5.291% | -11.396% | -77.204% | -82.199% |
Comments
Bruker (BRKR) had its price target raised by JPMorgan Chase & Co. from $55.00 to $65.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Order momentum is improving across Bruker’s business, with semiconductor metrology, overseas
